CLSA, Morgan Stanley, and Nomura bullish on SBI Life; stock available at attractive valuations – check targets here
A day after its quarter four results, the brokerage firms have raised expectations from this insurance company. CLSA, Morgan Stanley, and Nomura has given a Buy recommendation for SBI Life Insurance on the back of valuations, the value of new business, and distribution strength.
SBI Life’s value of new business (VoNB) increased by 16 per cent YoY: PTI